Functional degradation: A mechanism of NLRP1 inflammasome activation by diverse pathogen enzymes.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
05 04 2019
Historique:
received: 09 05 2018
revised: 05 11 2018
accepted: 05 03 2019
pubmed: 16 3 2019
medline: 21 6 2019
entrez: 16 3 2019
Statut: ppublish

Résumé

Inflammasomes are multiprotein platforms that initiate innate immunity by recruitment and activation of caspase-1. The NLRP1B inflammasome is activated upon direct cleavage by the anthrax lethal toxin protease. However, the mechanism by which cleavage results in NLRP1B activation is unknown. In this study, we find that cleavage results in proteasome-mediated degradation of the amino-terminal domains of NLRP1B, liberating a carboxyl-terminal fragment that is a potent caspase-1 activator. Proteasome-mediated degradation of NLRP1B is both necessary and sufficient for NLRP1B activation. Consistent with our functional degradation model, we identify IpaH7.8, a

Identifiants

pubmed: 30872533
pii: science.aau1330
doi: 10.1126/science.aau1330
pmc: PMC6532986
mid: NIHMS1026604
pii:
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
Antigens, Bacterial 0
Apoptosis Regulatory Proteins 0
Bacterial Proteins 0
Bacterial Toxins 0
CARD Signaling Adaptor Proteins 0
CARD8 protein, human 0
Death Domain Receptor Signaling Adaptor Proteins 0
Inflammasomes 0
NLR Proteins 0
NLRP1 protein, human 0
Neoplasm Proteins 0
PIDD1 protein, human 0
Protein Subunits 0
anthrax toxin 0
ipaH protein, Shigella flexneri 0
Ubiquitin-Protein Ligases EC 2.3.2.27
Peptide Hydrolases EC 3.4.-
Caspase 1 EC 3.4.22.36
Proteasome Endopeptidase Complex EC 3.4.25.1

Types de publication

Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R37 AI075039
Pays : United States
Organisme : NIAID NIH HHS
ID : R56 AI064285
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI155634
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI063302
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI064285
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI075039
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Références

Infect Immun. 1999 Jun;67(6):3055-60
pubmed: 10338520
Infect Immun. 2000 Jun;68(6):3608-19
pubmed: 10816519
Mol Cell. 2002 Aug;10(2):417-26
pubmed: 12191486
Science. 2003 Aug 29;301(5637):1230-3
pubmed: 12947197
Nat Genet. 2006 Feb;38(2):240-4
pubmed: 16429160
Nature. 2006 Nov 16;444(7117):323-9
pubmed: 17108957
Cell Microbiol. 2008 Feb;10(2):332-43
pubmed: 17850338
J Biol Chem. 2007 Nov 23;282(47):34260-7
pubmed: 17878154
Cell Host Microbe. 2007 Mar 15;1(1):77-83
pubmed: 18005683
Cell Microbiol. 2008 Jun;10(6):1352-62
pubmed: 18266992
Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4312-7
pubmed: 18337499
Nat Struct Mol Biol. 2008 Dec;15(12):1293-301
pubmed: 18997778
Nat Struct Mol Biol. 2008 Dec;15(12):1302-8
pubmed: 18997779
Cell Host Microbe. 2009 Jul 23;6(1):10-21
pubmed: 19616762
Infect Immun. 2009 Oct;77(10):4455-62
pubmed: 19651869
Nat Methods. 2009 Dec;6(12):917-22
pubmed: 19915560
PLoS Pathog. 2011 Feb;7(2):e1001289
pubmed: 21390206
Protein Sci. 2011 Aug;20(8):1298-345
pubmed: 21633985
PLoS One. 2011;6(11):e27396
pubmed: 22087307
Nat Rev Immunol. 2012 Feb 24;12(3):215-25
pubmed: 22362354
Cell Microbiol. 2012 Jul;14(7):1071-84
pubmed: 22372664
PLoS Pathog. 2012;8(3):e1002638
pubmed: 22479187
PLoS Pathog. 2012;8(4):e1002659
pubmed: 22536155
J Biol Chem. 2012 Jul 20;287(30):25030-7
pubmed: 22665479
Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):E3350-7
pubmed: 23150568
PLoS One. 2012;7(11):e49741
pubmed: 23152930
Infect Immun. 2013 Feb;81(2):570-9
pubmed: 23230290
Nature. 2013 Apr 11;496(7444):233-7
pubmed: 23542589
PLoS Pathog. 2013;9(6):e1003452
pubmed: 23818853
Proc Natl Acad Sci U S A. 2013 Aug 27;110(35):14408-13
pubmed: 23940371
Infect Immun. 2014 Jan;82(1):460-8
pubmed: 24218483
Trends Biochem Sci. 2014 Feb;39(2):53-60
pubmed: 24316303
PLoS Pathog. 2014 Feb 06;10(2):e1003926
pubmed: 24516390
MBio. 2014 Feb 18;5(1):null
pubmed: 24549849
PLoS Pathog. 2014 Mar 13;10(3):e1003927
pubmed: 24626226
Nature. 2014 Sep 11;513(7517):237-41
pubmed: 24919149
Infect Immun. 2014 Sep;82(9):3697-703
pubmed: 24935976
J Biol Chem. 1989 Oct 5;264(28):16700-12
pubmed: 2506181
Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):E4254-63
pubmed: 25246571
Immunol Rev. 2015 May;265(1):22-34
pubmed: 25879281
Cell Res. 2016 Apr;26(4):499-510
pubmed: 26964724
Nature. 2016 Apr 21;532(7599):394-7
pubmed: 27007849
Cold Spring Harb Symp Quant Biol. 1989;54 Pt 1:1-13
pubmed: 2700931
Cell. 2016 May 5;165(4):792-800
pubmed: 27153493
Nat Rev Immunol. 2016 Jul;16(7):407-20
pubmed: 27291964
Curr Top Microbiol Immunol. 2016;397:91-115
pubmed: 27460806
Cell Host Microbe. 2016 Sep 14;20(3):296-306
pubmed: 27569559
Cell. 2016 Sep 22;167(1):187-202.e17
pubmed: 27662089
PLoS Pathog. 2016 Dec 2;12(12):e1006035
pubmed: 27911947
PLoS Pathog. 2016 Dec 7;12(12):e1006052
pubmed: 27926929
Science. 2016 Dec 2;354(6316):
pubmed: 27934708
Curr Opin Struct Biol. 2017 Jun;44:101-110
pubmed: 28130986
Infect Immun. 2017 Oct 18;85(11):
pubmed: 28808162
Proc Natl Acad Sci U S A. 2017 Dec 12;114(50):13242-13247
pubmed: 29180436
Cell Chem Biol. 2018 Mar 15;25(3):262-267.e5
pubmed: 29396289
Science. 1986 Oct 10;234(4773):179-86
pubmed: 3018930

Auteurs

Andrew Sandstrom (A)

Division of Immunology and Pathogenesis, Department of Molecular & Cell Biology, and Cancer Research Laboratory, University of California, Berkeley, CA, USA.
Howard Hughes Medical Institute, University of California, Berkeley, CA, USA.

Patrick S Mitchell (PS)

Division of Immunology and Pathogenesis, Department of Molecular & Cell Biology, and Cancer Research Laboratory, University of California, Berkeley, CA, USA.

Lisa Goers (L)

Department of Microbiology, Harvard Medical School, Boston, MA, USA.
Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Department of Medicine, Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.

Edward W Mu (EW)

Division of Immunology and Pathogenesis, Department of Molecular & Cell Biology, and Cancer Research Laboratory, University of California, Berkeley, CA, USA.

Cammie F Lesser (CF)

Department of Microbiology, Harvard Medical School, Boston, MA, USA.
Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Department of Medicine, Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.

Russell E Vance (RE)

Division of Immunology and Pathogenesis, Department of Molecular & Cell Biology, and Cancer Research Laboratory, University of California, Berkeley, CA, USA. rvance@berkeley.edu.
Howard Hughes Medical Institute, University of California, Berkeley, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH